STIKO-Tätigkeit

Mitglied seit März 2024

Mitgliedschaft in folgenden Arbeitsgruppen (AG):

• AG Methodik
• AG Pneumokokken (Sprecher)
• AG Respiratorische Synzytial-Viren
  

Institutionszugehörigkeit

Professor für Infektionsdynamik und Globale Gesundheit
Charité Center for Global Health
Charité – Universitätsmedizin Berlin
Charitéplatz 1
10117 Berlin–Mitte

Professor of Vaccine Epidemiology
London School of Hygiene & Tropical Medicine
Keppel Street
WC1E 7HT London

Arbeitsschwerpunkte in der Impfprävention

• Infektionsepidemiologische Modellierung
• Vakzine-Epidemiologie

Beruflicher Werdegang

• Seit 2024 Einstein Professor for Infectious Disease Dynamics and Global Health an der Charité Berlin
• Seit 2020 Professor of Vaccine Epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM)
• 2016–2020 Associate Professor at LSHTM
• 2014–2016 Assistant Professor at LSHTM
• 2013–2014 Research Fellow at LSHTM
• 2012-2013 Research Consultant for LSHTM based in Vietnam (3 months)

• 2009 Research Assistant at Health Protection Agency, London

• 2007-2008 Wissenschaftlicher Mitarbeiter am Robert Koch-Institut, Berlin

Selbstauskunft

Interessenskonflikte, die den Anschein der Befangenheit begründen:
Keine

• Seit 2022 Mitglied im WHO Immunization and vaccines related implementation research advisory committee (IVIR-AC)
• Seit 2018 Mitglied im Joint Committee on Vaccination and Immunisation’s (JCVI) Pneumococcal sub-committee (UK)
• Seit 2016 Mitglied in der WHO Strategic Advisory Group of Experts (SAGE) on Immunisation’s Working Group on pneumococcal conjugate vaccines
• 2022 - 2024 Mitglied in der WHO-SAGE Immunisation’s Working Group on COVID-19 vaccines
• 2022- 2024 Ko-Vorsitzender der WHO-SAGE Immunisation’s Working Sub-group on COIVD-19 modelling
• 2018 - 2019 Mitglied in der WHO-SAGE Immunisation’s Working Group on dengue vaccines

Ausgewählte Publikationen

• den Boon, S., Jit, M. Brisson, M., Medley, G., Beutels, P., White, R., Flasche, S. et al., Guidelines for multi-model comparisons of the impact of infectious disease interventions. BMC Med, 2019. 17(1): p. 163.
• Wilder-Smith, A., Flasche, S., and Smith, P-G., Vaccine-attributable severe dengue in the Philippines. Lancet, 2019. 394(10215): p. 2151-2152.
• Flasche, S., et al., The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries. PLoS Med, 2015. 12(6): p. e1001839.
• Lambach P, Orenstein W, Silal S, Sbarra AN, Koh M, Aggarwal R, Hasan Farooqui H, Flasche, S, Hogan A, Kim SY, Leask J, Luz PM, Lyimo DC, Moss WJ, Pitzer VE, Wang XY, Wu J. Report from the World Health Organization's immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11-13 September 2023. Vaccine. 2024 Mar 7;42(7):1424-1434. doi: 10.1016/j.vaccine.2024.02.014. Epub 2024 Feb 6. PMID: 38326131.

• Hodgson D, Koltai M, Krauer F, Flasche, S, Jit M, Atkins KE. Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales. Vaccine. 2022 Nov 22;40(49):7151-7157. doi: 10.1016/j.vaccine.2022.10.041. Epub 2022 Oct 31. PMID: 36328884.

• Thindwa D, Garcia Quesada M, Liu Y, Bennett J, Cohen C, Knoll MD, von Gottberg A, Hayford K, Flasche, S. Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality. Vaccine. 2020 Jul 22;38(34):5398-5401. doi: 10.1016/j.vaccine.2020.06.047. Epub 2020 Jun 19. PMID: 32600911; PMCID: PMC7303659.

• van Zandvoort K, Checchi F, Diggle E, Eggo RM, Gadroen K, Mulholland K, McGowan CR, le Polain de Waroux O, Rao VB, Satzke C, Flasche, S. Pneumococcal conjugate vaccine use during humanitarian crises. Vaccine. 2019 Oct 23;37(45):6787-6792. doi: 10.1016/j.vaccine.2019.09.038. Epub 2019 Sep 24. PMID: 31562004.

• Flasche, S. The scope for pneumococcal vaccines that do not prevent transmission. Vaccine. 2017 Oct 27;35(45):6043-6046. doi: 10.1016/j.vaccine.2017.09.073. Epub 2017 Oct 3. PMID: 28982625.

• Ojal J, Flasche, S, Hammitt LL, Akech D, Kiti MC, Kamau T, Adetifa I, Nurhonen M, Scott JAG, Auranen K. Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data. Vaccine. 2017 Aug 16;35(35 Pt B):4561-4568. doi: 10.1016/j.vaccine.2017.07.019. Epub 2017 Jul 17. PMID: 28729018; PMCID: PMC5571446.